Consort Medical plc (LON:CSRT) insider Paul Hayes bought 14 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The shares were acquired at an average price of GBX 1,119 ($14.62) per share, for a total transaction of £156.66 ($204.70).

Paul Hayes also recently made the following trade(s):

  • On Friday, September 7th, Paul Hayes bought 12 shares of Consort Medical stock. The shares were acquired at an average price of GBX 1,220 ($15.94) per share, for a total transaction of £146.40 ($191.30).

Shares of Consort Medical stock opened at GBX 1,110 ($14.50) on Friday. Consort Medical plc has a twelve month low of GBX 976.09 ($12.75) and a twelve month high of GBX 1,230 ($16.07).

Separately, Shore Capital reiterated a “hold” rating on shares of Consort Medical in a research report on Monday, September 10th.

COPYRIGHT VIOLATION NOTICE: “Insider Buying: Consort Medical plc (CSRT) Insider Acquires 14 Shares of Stock” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://theolympiareport.com/2018/11/11/insider-buying-consort-medical-plc-csrt-insider-acquires-14-shares-of-stock.html.

About Consort Medical

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.

Featured Story: What is the 52-week high/low?

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.